Pomalyst
Drug timelines are a Plus or Pro feature.
67 regulatory and trial events tracked for Pomalyst, covering 2013-02-08 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma [Phase 1]